In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lanacordin Drug Master File in Korea (Lanacordin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lanacordin. The MFDS reviews the Lanacordin KDMF as part of the drug registration process and uses the information provided in the Lanacordin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lanacordin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lanacordin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lanacordin suppliers with KDMF on PharmaCompass.